SPRÜHTROCKNUNGSFORMULIERUNGEN

Patent europeic · EP3054937 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3054937
Numer da la dumonda
EP14852309
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-10-2014
Publitgà
17-08-2016
Concedì
26-07-2023
La protecziun finescha il pli tard
09-10-2034
Proxima taxa annuala scadenta
31-10-2027
Classas IPC
A61K 31/497 (2006.01)
A61K 9/00 (2006.01)
A61P 11/00 (2006.01)
Prioritad
US 201361889887 P 11.10.2013
Dumonda PCT
PCT/US2014/060039 10.10.2014
Publicaziun PCT
WO2015/054574 16.04.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-11-2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. 01-11-2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  3. 01-11-2024

    Next annual fee due on

    Next annual fee due on
    31.10.2024 → 31.10.2025

    Published in Swissreg on 01.11.2024

  4. 05-06-2024

    Midada

    Published in Swissreg on 05.06.2024

  5. 01-11-2023

    Midada

    Published in Swissreg on 01.11.2023

  6. 26-07-2023

    Concedì

    Published in Swissreg on 26.07.2023

Partidas

Possessur

Pulmokine, Inc.

7 University Place, Lab Location - RM B127, Rensselaer, NY 12144, US

Gilead Sciences, Inc.

333 Lakeside Drive, Foster City, CA 94404, US

Inventur

ZISMAN, Lawrence, S.

New York 12159, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.